nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP2C8—Tazarotene—psoriasis	0.109	0.134	CbGbCtD
Halofantrine—CYP3A5—Beclomethasone—psoriasis	0.105	0.129	CbGbCtD
Halofantrine—CYP2D6—Hydroxyurea—psoriasis	0.0489	0.0601	CbGbCtD
Halofantrine—CYP2C8—Cholecalciferol—psoriasis	0.0464	0.0571	CbGbCtD
Halofantrine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0418	0.0515	CbGbCtD
Halofantrine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0402	0.0495	CbGbCtD
Halofantrine—CYP3A4—Calcitriol—psoriasis	0.0365	0.0449	CbGbCtD
Halofantrine—CYP3A5—Hydrocortisone—psoriasis	0.0336	0.0413	CbGbCtD
Halofantrine—CYP2C8—Hydrocortisone—psoriasis	0.0323	0.0397	CbGbCtD
Halofantrine—CYP3A5—Cyclosporine—psoriasis	0.0317	0.039	CbGbCtD
Halofantrine—CYP2C8—Cyclosporine—psoriasis	0.0305	0.0375	CbGbCtD
Halofantrine—CYP2D6—Cholecalciferol—psoriasis	0.0296	0.0364	CbGbCtD
Halofantrine—CYP3A4—Methoxsalen—psoriasis	0.0284	0.0349	CbGbCtD
Halofantrine—CYP3A5—Dexamethasone—psoriasis	0.0209	0.0257	CbGbCtD
Halofantrine—CYP2C8—Dexamethasone—psoriasis	0.0201	0.0247	CbGbCtD
Halofantrine—CYP2D6—Cyclosporine—psoriasis	0.0194	0.0239	CbGbCtD
Halofantrine—CYP3A4—Cholecalciferol—psoriasis	0.0188	0.0231	CbGbCtD
Halofantrine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0163	0.0201	CbGbCtD
Halofantrine—CYP3A4—Triamcinolone—psoriasis	0.0163	0.0201	CbGbCtD
Halofantrine—CYP3A4—Betamethasone—psoriasis	0.014	0.0172	CbGbCtD
Halofantrine—CYP3A4—Prednisolone—psoriasis	0.0138	0.017	CbGbCtD
Halofantrine—CYP3A4—Hydrocortisone—psoriasis	0.0131	0.0161	CbGbCtD
Halofantrine—CYP3A4—Prednisone—psoriasis	0.013	0.016	CbGbCtD
Halofantrine—CYP2D6—Dexamethasone—psoriasis	0.0128	0.0157	CbGbCtD
Halofantrine—CYP3A4—Cyclosporine—psoriasis	0.0124	0.0152	CbGbCtD
Halofantrine—CYP3A4—Dexamethasone—psoriasis	0.00814	0.01	CbGbCtD
Halofantrine—Palpitations—Mycophenolate mofetil—psoriasis	0.000321	0.00172	CcSEcCtD
Halofantrine—Arrhythmia—Triamcinolone—psoriasis	0.000319	0.00171	CcSEcCtD
Halofantrine—Arthralgia—Cyclosporine—psoriasis	0.000317	0.0017	CcSEcCtD
Halofantrine—Chest pain—Cyclosporine—psoriasis	0.000317	0.0017	CcSEcCtD
Halofantrine—Myalgia—Cyclosporine—psoriasis	0.000317	0.0017	CcSEcCtD
Halofantrine—Cough—Mycophenolate mofetil—psoriasis	0.000317	0.0017	CcSEcCtD
Halofantrine—Convulsion—Mycophenolate mofetil—psoriasis	0.000314	0.00168	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisolone—psoriasis	0.000314	0.00168	CcSEcCtD
Halofantrine—Discomfort—Cyclosporine—psoriasis	0.000313	0.00168	CcSEcCtD
Halofantrine—Visual impairment—Dexamethasone—psoriasis	0.000313	0.00167	CcSEcCtD
Halofantrine—Visual impairment—Betamethasone—psoriasis	0.000313	0.00167	CcSEcCtD
Halofantrine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000309	0.00166	CcSEcCtD
Halofantrine—Chest pain—Mycophenolate mofetil—psoriasis	0.000309	0.00165	CcSEcCtD
Halofantrine—Arthralgia—Mycophenolate mofetil—psoriasis	0.000309	0.00165	CcSEcCtD
Halofantrine—Myalgia—Mycophenolate mofetil—psoriasis	0.000309	0.00165	CcSEcCtD
Halofantrine—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000307	0.00164	CcSEcCtD
Halofantrine—Ill-defined disorder—Hydrocortisone—psoriasis	0.000307	0.00164	CcSEcCtD
Halofantrine—Diarrhoea—Hydroxyurea—psoriasis	0.000307	0.00164	CcSEcCtD
Halofantrine—Confusional state—Cyclosporine—psoriasis	0.000306	0.00164	CcSEcCtD
Halofantrine—Malaise—Prednisolone—psoriasis	0.000305	0.00163	CcSEcCtD
Halofantrine—Discomfort—Mycophenolate mofetil—psoriasis	0.000305	0.00163	CcSEcCtD
Halofantrine—Anaphylactic shock—Cyclosporine—psoriasis	0.000304	0.00163	CcSEcCtD
Halofantrine—Back pain—Triamcinolone—psoriasis	0.000301	0.00161	CcSEcCtD
Halofantrine—Confusional state—Mycophenolate mofetil—psoriasis	0.000299	0.0016	CcSEcCtD
Halofantrine—Malaise—Hydrocortisone—psoriasis	0.000298	0.0016	CcSEcCtD
Halofantrine—Abdominal pain—Mycophenolic acid—psoriasis	0.000297	0.00159	CcSEcCtD
Halofantrine—Dizziness—Hydroxyurea—psoriasis	0.000296	0.00159	CcSEcCtD
Halofantrine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000296	0.00159	CcSEcCtD
Halofantrine—Convulsion—Prednisolone—psoriasis	0.000293	0.00157	CcSEcCtD
Halofantrine—Arrhythmia—Betamethasone—psoriasis	0.00029	0.00155	CcSEcCtD
Halofantrine—Arrhythmia—Dexamethasone—psoriasis	0.00029	0.00155	CcSEcCtD
Halofantrine—Anorexia—Cyclosporine—psoriasis	0.000289	0.00155	CcSEcCtD
Halofantrine—Ill-defined disorder—Triamcinolone—psoriasis	0.000289	0.00155	CcSEcCtD
Halofantrine—Convulsion—Hydrocortisone—psoriasis	0.000286	0.00153	CcSEcCtD
Halofantrine—Vomiting—Hydroxyurea—psoriasis	0.000285	0.00153	CcSEcCtD
Halofantrine—Discomfort—Prednisolone—psoriasis	0.000285	0.00152	CcSEcCtD
Halofantrine—Rash—Hydroxyurea—psoriasis	0.000282	0.00151	CcSEcCtD
Halofantrine—Anorexia—Mycophenolate mofetil—psoriasis	0.000282	0.00151	CcSEcCtD
Halofantrine—Dermatitis—Hydroxyurea—psoriasis	0.000282	0.00151	CcSEcCtD
Halofantrine—Myalgia—Hydrocortisone—psoriasis	0.000281	0.00151	CcSEcCtD
Halofantrine—Malaise—Triamcinolone—psoriasis	0.000281	0.0015	CcSEcCtD
Halofantrine—Headache—Hydroxyurea—psoriasis	0.000281	0.0015	CcSEcCtD
Halofantrine—Discomfort—Hydrocortisone—psoriasis	0.000278	0.00149	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000277	0.00148	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisolone—psoriasis	0.000276	0.00148	CcSEcCtD
Halofantrine—Paraesthesia—Cyclosporine—psoriasis	0.000273	0.00146	CcSEcCtD
Halofantrine—Cough—Triamcinolone—psoriasis	0.000272	0.00145	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.00027	0.00145	CcSEcCtD
Halofantrine—Anaphylactic shock—Hydrocortisone—psoriasis	0.00027	0.00145	CcSEcCtD
Halofantrine—Convulsion—Triamcinolone—psoriasis	0.00027	0.00144	CcSEcCtD
Halofantrine—Asthenia—Mycophenolic acid—psoriasis	0.000269	0.00144	CcSEcCtD
Halofantrine—Dyspepsia—Cyclosporine—psoriasis	0.000267	0.00143	CcSEcCtD
Halofantrine—Nausea—Hydroxyurea—psoriasis	0.000266	0.00143	CcSEcCtD
Halofantrine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000266	0.00142	CcSEcCtD
Halofantrine—Pruritus—Mycophenolic acid—psoriasis	0.000265	0.00142	CcSEcCtD
Halofantrine—Myalgia—Triamcinolone—psoriasis	0.000265	0.00142	CcSEcCtD
Halofantrine—Decreased appetite—Cyclosporine—psoriasis	0.000264	0.00141	CcSEcCtD
Halofantrine—Ill-defined disorder—Dexamethasone—psoriasis	0.000262	0.0014	CcSEcCtD
Halofantrine—Ill-defined disorder—Betamethasone—psoriasis	0.000262	0.0014	CcSEcCtD
Halofantrine—Discomfort—Triamcinolone—psoriasis	0.000262	0.0014	CcSEcCtD
Halofantrine—Fatigue—Cyclosporine—psoriasis	0.000262	0.0014	CcSEcCtD
Halofantrine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000261	0.0014	CcSEcCtD
Halofantrine—Constipation—Cyclosporine—psoriasis	0.00026	0.00139	CcSEcCtD
Halofantrine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000257	0.00138	CcSEcCtD
Halofantrine—Anorexia—Hydrocortisone—psoriasis	0.000257	0.00138	CcSEcCtD
Halofantrine—Diarrhoea—Mycophenolic acid—psoriasis	0.000257	0.00138	CcSEcCtD
Halofantrine—Stomatitis—Methotrexate—psoriasis	0.000256	0.00137	CcSEcCtD
Halofantrine—Malaise—Dexamethasone—psoriasis	0.000255	0.00136	CcSEcCtD
Halofantrine—Malaise—Betamethasone—psoriasis	0.000255	0.00136	CcSEcCtD
Halofantrine—Anaphylactic shock—Triamcinolone—psoriasis	0.000254	0.00136	CcSEcCtD
Halofantrine—Constipation—Mycophenolate mofetil—psoriasis	0.000253	0.00136	CcSEcCtD
Halofantrine—Arrhythmia—Prednisone—psoriasis	0.000252	0.00135	CcSEcCtD
Halofantrine—Feeling abnormal—Cyclosporine—psoriasis	0.00025	0.00134	CcSEcCtD
Halofantrine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000248	0.00133	CcSEcCtD
Halofantrine—Dizziness—Mycophenolic acid—psoriasis	0.000248	0.00133	CcSEcCtD
Halofantrine—Paraesthesia—Prednisolone—psoriasis	0.000248	0.00133	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000246	0.00132	CcSEcCtD
Halofantrine—Convulsion—Dexamethasone—psoriasis	0.000245	0.00131	CcSEcCtD
Halofantrine—Convulsion—Betamethasone—psoriasis	0.000245	0.00131	CcSEcCtD
Halofantrine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000244	0.00131	CcSEcCtD
Halofantrine—Paraesthesia—Hydrocortisone—psoriasis	0.000242	0.0013	CcSEcCtD
Halofantrine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000242	0.0013	CcSEcCtD
Halofantrine—Urticaria—Cyclosporine—psoriasis	0.000241	0.00129	CcSEcCtD
Halofantrine—Myalgia—Dexamethasone—psoriasis	0.00024	0.00129	CcSEcCtD
Halofantrine—Myalgia—Betamethasone—psoriasis	0.00024	0.00129	CcSEcCtD
Halofantrine—Abdominal pain—Cyclosporine—psoriasis	0.00024	0.00129	CcSEcCtD
Halofantrine—Vomiting—Mycophenolic acid—psoriasis	0.000239	0.00128	CcSEcCtD
Halofantrine—Discomfort—Dexamethasone—psoriasis	0.000238	0.00127	CcSEcCtD
Halofantrine—Discomfort—Betamethasone—psoriasis	0.000238	0.00127	CcSEcCtD
Halofantrine—Dyspepsia—Hydrocortisone—psoriasis	0.000237	0.00127	CcSEcCtD
Halofantrine—Rash—Mycophenolic acid—psoriasis	0.000237	0.00127	CcSEcCtD
Halofantrine—Dermatitis—Mycophenolic acid—psoriasis	0.000236	0.00127	CcSEcCtD
Halofantrine—Urticaria—Mycophenolate mofetil—psoriasis	0.000235	0.00126	CcSEcCtD
Halofantrine—Headache—Mycophenolic acid—psoriasis	0.000235	0.00126	CcSEcCtD
Halofantrine—Decreased appetite—Hydrocortisone—psoriasis	0.000235	0.00126	CcSEcCtD
Halofantrine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000234	0.00125	CcSEcCtD
Halofantrine—Fatigue—Hydrocortisone—psoriasis	0.000233	0.00125	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000231	0.00124	CcSEcCtD
Halofantrine—Anaphylactic shock—Dexamethasone—psoriasis	0.00023	0.00123	CcSEcCtD
Halofantrine—Anaphylactic shock—Betamethasone—psoriasis	0.00023	0.00123	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisone—psoriasis	0.000228	0.00122	CcSEcCtD
Halofantrine—Paraesthesia—Triamcinolone—psoriasis	0.000228	0.00122	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisolone—psoriasis	0.000228	0.00122	CcSEcCtD
Halofantrine—Visual impairment—Methotrexate—psoriasis	0.000228	0.00122	CcSEcCtD
Halofantrine—Dyspepsia—Triamcinolone—psoriasis	0.000224	0.0012	CcSEcCtD
Halofantrine—Nausea—Mycophenolic acid—psoriasis	0.000223	0.00119	CcSEcCtD
Halofantrine—Feeling abnormal—Hydrocortisone—psoriasis	0.000222	0.00119	CcSEcCtD
Halofantrine—Malaise—Prednisone—psoriasis	0.000222	0.00119	CcSEcCtD
Halofantrine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000221	0.00118	CcSEcCtD
Halofantrine—Tinnitus—Methotrexate—psoriasis	0.00022	0.00118	CcSEcCtD
Halofantrine—Anorexia—Betamethasone—psoriasis	0.00022	0.00118	CcSEcCtD
Halofantrine—Anorexia—Dexamethasone—psoriasis	0.00022	0.00118	CcSEcCtD
Halofantrine—Urticaria—Prednisolone—psoriasis	0.000219	0.00118	CcSEcCtD
Halofantrine—Fatigue—Triamcinolone—psoriasis	0.000219	0.00117	CcSEcCtD
Halofantrine—Asthenia—Cyclosporine—psoriasis	0.000218	0.00117	CcSEcCtD
Halofantrine—Pruritus—Cyclosporine—psoriasis	0.000215	0.00115	CcSEcCtD
Halofantrine—Urticaria—Hydrocortisone—psoriasis	0.000214	0.00115	CcSEcCtD
Halofantrine—Abdominal pain—Hydrocortisone—psoriasis	0.000213	0.00114	CcSEcCtD
Halofantrine—Convulsion—Prednisone—psoriasis	0.000213	0.00114	CcSEcCtD
Halofantrine—Asthenia—Mycophenolate mofetil—psoriasis	0.000212	0.00114	CcSEcCtD
Halofantrine—Chills—Methotrexate—psoriasis	0.000212	0.00113	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.00021	0.00112	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.00021	0.00112	CcSEcCtD
Halofantrine—Pruritus—Mycophenolate mofetil—psoriasis	0.000209	0.00112	CcSEcCtD
Halofantrine—Arthralgia—Prednisone—psoriasis	0.000209	0.00112	CcSEcCtD
Halofantrine—Myalgia—Prednisone—psoriasis	0.000209	0.00112	CcSEcCtD
Halofantrine—Feeling abnormal—Triamcinolone—psoriasis	0.000209	0.00112	CcSEcCtD
Halofantrine—Diarrhoea—Cyclosporine—psoriasis	0.000208	0.00111	CcSEcCtD
Halofantrine—Paraesthesia—Betamethasone—psoriasis	0.000207	0.00111	CcSEcCtD
Halofantrine—Paraesthesia—Dexamethasone—psoriasis	0.000207	0.00111	CcSEcCtD
Halofantrine—Discomfort—Prednisone—psoriasis	0.000207	0.00111	CcSEcCtD
Halofantrine—Dyspepsia—Betamethasone—psoriasis	0.000203	0.00109	CcSEcCtD
Halofantrine—Dyspepsia—Dexamethasone—psoriasis	0.000203	0.00109	CcSEcCtD
Halofantrine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000203	0.00109	CcSEcCtD
Halofantrine—Urticaria—Triamcinolone—psoriasis	0.000202	0.00108	CcSEcCtD
Halofantrine—Dizziness—Cyclosporine—psoriasis	0.000201	0.00108	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisone—psoriasis	0.000201	0.00108	CcSEcCtD
Halofantrine—Decreased appetite—Dexamethasone—psoriasis	0.0002	0.00107	CcSEcCtD
Halofantrine—Decreased appetite—Betamethasone—psoriasis	0.0002	0.00107	CcSEcCtD
Halofantrine—Back pain—Methotrexate—psoriasis	0.000199	0.00106	CcSEcCtD
Halofantrine—Fatigue—Betamethasone—psoriasis	0.000199	0.00106	CcSEcCtD
Halofantrine—Fatigue—Dexamethasone—psoriasis	0.000199	0.00106	CcSEcCtD
Halofantrine—Dizziness—Mycophenolate mofetil—psoriasis	0.000196	0.00105	CcSEcCtD
Halofantrine—Asthenia—Hydrocortisone—psoriasis	0.000194	0.00104	CcSEcCtD
Halofantrine—Vomiting—Cyclosporine—psoriasis	0.000193	0.00103	CcSEcCtD
Halofantrine—Rash—Cyclosporine—psoriasis	0.000191	0.00103	CcSEcCtD
Halofantrine—Anorexia—Prednisone—psoriasis	0.000191	0.00102	CcSEcCtD
Halofantrine—Dermatitis—Cyclosporine—psoriasis	0.000191	0.00102	CcSEcCtD
Halofantrine—Pruritus—Hydrocortisone—psoriasis	0.000191	0.00102	CcSEcCtD
Halofantrine—Ill-defined disorder—Methotrexate—psoriasis	0.000191	0.00102	CcSEcCtD
Halofantrine—Headache—Cyclosporine—psoriasis	0.00019	0.00102	CcSEcCtD
Halofantrine—Feeling abnormal—Betamethasone—psoriasis	0.00019	0.00102	CcSEcCtD
Halofantrine—Feeling abnormal—Dexamethasone—psoriasis	0.00019	0.00102	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000188	0.00101	CcSEcCtD
Halofantrine—Gastrointestinal pain—Betamethasone—psoriasis	0.000188	0.00101	CcSEcCtD
Halofantrine—Vomiting—Mycophenolate mofetil—psoriasis	0.000188	0.00101	CcSEcCtD
Halofantrine—Rash—Mycophenolate mofetil—psoriasis	0.000187	0.001	CcSEcCtD
Halofantrine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000187	0.000999	CcSEcCtD
Halofantrine—Headache—Mycophenolate mofetil—psoriasis	0.000186	0.000994	CcSEcCtD
Halofantrine—Malaise—Methotrexate—psoriasis	0.000185	0.000993	CcSEcCtD
Halofantrine—Diarrhoea—Hydrocortisone—psoriasis	0.000185	0.000989	CcSEcCtD
Halofantrine—Urticaria—Dexamethasone—psoriasis	0.000183	0.000981	CcSEcCtD
Halofantrine—Urticaria—Betamethasone—psoriasis	0.000183	0.000981	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000183	0.00098	CcSEcCtD
Halofantrine—Dizziness—Prednisolone—psoriasis	0.000183	0.000978	CcSEcCtD
Halofantrine—Asthenia—Triamcinolone—psoriasis	0.000182	0.000976	CcSEcCtD
Halofantrine—Abdominal pain—Dexamethasone—psoriasis	0.000182	0.000976	CcSEcCtD
Halofantrine—Abdominal pain—Betamethasone—psoriasis	0.000182	0.000976	CcSEcCtD
Halofantrine—Nausea—Cyclosporine—psoriasis	0.00018	0.000966	CcSEcCtD
Halofantrine—Paraesthesia—Prednisone—psoriasis	0.00018	0.000965	CcSEcCtD
Halofantrine—Pruritus—Triamcinolone—psoriasis	0.00018	0.000963	CcSEcCtD
Halofantrine—Cough—Methotrexate—psoriasis	0.000179	0.000961	CcSEcCtD
Halofantrine—Dizziness—Hydrocortisone—psoriasis	0.000178	0.000956	CcSEcCtD
Halofantrine—Convulsion—Methotrexate—psoriasis	0.000178	0.000954	CcSEcCtD
Halofantrine—Dyspepsia—Prednisone—psoriasis	0.000177	0.000946	CcSEcCtD
Halofantrine—Nausea—Mycophenolate mofetil—psoriasis	0.000176	0.000942	CcSEcCtD
Halofantrine—Chest pain—Methotrexate—psoriasis	0.000175	0.000937	CcSEcCtD
Halofantrine—Myalgia—Methotrexate—psoriasis	0.000175	0.000937	CcSEcCtD
Halofantrine—Arthralgia—Methotrexate—psoriasis	0.000175	0.000937	CcSEcCtD
Halofantrine—Decreased appetite—Prednisone—psoriasis	0.000174	0.000935	CcSEcCtD
Halofantrine—Rash—Prednisolone—psoriasis	0.000174	0.000933	CcSEcCtD
Halofantrine—Dermatitis—Prednisolone—psoriasis	0.000174	0.000932	CcSEcCtD
Halofantrine—Fatigue—Prednisone—psoriasis	0.000173	0.000927	CcSEcCtD
Halofantrine—Headache—Prednisolone—psoriasis	0.000173	0.000927	CcSEcCtD
Halofantrine—Discomfort—Methotrexate—psoriasis	0.000173	0.000926	CcSEcCtD
Halofantrine—Constipation—Prednisone—psoriasis	0.000172	0.000919	CcSEcCtD
Halofantrine—Vomiting—Hydrocortisone—psoriasis	0.000172	0.000919	CcSEcCtD
Halofantrine—Rash—Hydrocortisone—psoriasis	0.00017	0.000911	CcSEcCtD
Halofantrine—Dermatitis—Hydrocortisone—psoriasis	0.00017	0.00091	CcSEcCtD
Halofantrine—Confusional state—Methotrexate—psoriasis	0.000169	0.000906	CcSEcCtD
Halofantrine—Headache—Hydrocortisone—psoriasis	0.000169	0.000905	CcSEcCtD
Halofantrine—Dizziness—Triamcinolone—psoriasis	0.000168	0.0009	CcSEcCtD
Halofantrine—Anaphylactic shock—Methotrexate—psoriasis	0.000168	0.000899	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisone—psoriasis	0.000165	0.000886	CcSEcCtD
Halofantrine—Asthenia—Dexamethasone—psoriasis	0.000165	0.000886	CcSEcCtD
Halofantrine—Asthenia—Betamethasone—psoriasis	0.000165	0.000886	CcSEcCtD
Halofantrine—Gastrointestinal pain—Prednisone—psoriasis	0.000164	0.000879	CcSEcCtD
Halofantrine—Nausea—Prednisolone—psoriasis	0.000164	0.000879	CcSEcCtD
Halofantrine—Pruritus—Betamethasone—psoriasis	0.000163	0.000873	CcSEcCtD
Halofantrine—Pruritus—Dexamethasone—psoriasis	0.000163	0.000873	CcSEcCtD
Halofantrine—Vomiting—Triamcinolone—psoriasis	0.000162	0.000865	CcSEcCtD
Halofantrine—Nausea—Hydrocortisone—psoriasis	0.00016	0.000858	CcSEcCtD
Halofantrine—Rash—Triamcinolone—psoriasis	0.00016	0.000858	CcSEcCtD
Halofantrine—Dermatitis—Triamcinolone—psoriasis	0.00016	0.000857	CcSEcCtD
Halofantrine—Anorexia—Methotrexate—psoriasis	0.00016	0.000856	CcSEcCtD
Halofantrine—Urticaria—Prednisone—psoriasis	0.000159	0.000854	CcSEcCtD
Halofantrine—Headache—Triamcinolone—psoriasis	0.000159	0.000852	CcSEcCtD
Halofantrine—Abdominal pain—Prednisone—psoriasis	0.000159	0.00085	CcSEcCtD
Halofantrine—Diarrhoea—Dexamethasone—psoriasis	0.000158	0.000845	CcSEcCtD
Halofantrine—Diarrhoea—Betamethasone—psoriasis	0.000158	0.000845	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000153	0.000819	CcSEcCtD
Halofantrine—Dizziness—Betamethasone—psoriasis	0.000152	0.000816	CcSEcCtD
Halofantrine—Dizziness—Dexamethasone—psoriasis	0.000152	0.000816	CcSEcCtD
Halofantrine—Nausea—Triamcinolone—psoriasis	0.000151	0.000808	CcSEcCtD
Halofantrine—Paraesthesia—Methotrexate—psoriasis	0.000151	0.000807	CcSEcCtD
Halofantrine—Dyspepsia—Methotrexate—psoriasis	0.000148	0.000791	CcSEcCtD
Halofantrine—Vomiting—Dexamethasone—psoriasis	0.000147	0.000785	CcSEcCtD
Halofantrine—Vomiting—Betamethasone—psoriasis	0.000147	0.000785	CcSEcCtD
Halofantrine—Decreased appetite—Methotrexate—psoriasis	0.000146	0.000781	CcSEcCtD
Halofantrine—Rash—Dexamethasone—psoriasis	0.000145	0.000778	CcSEcCtD
Halofantrine—Rash—Betamethasone—psoriasis	0.000145	0.000778	CcSEcCtD
Halofantrine—Dermatitis—Dexamethasone—psoriasis	0.000145	0.000778	CcSEcCtD
Halofantrine—Dermatitis—Betamethasone—psoriasis	0.000145	0.000778	CcSEcCtD
Halofantrine—Fatigue—Methotrexate—psoriasis	0.000145	0.000775	CcSEcCtD
Halofantrine—Headache—Betamethasone—psoriasis	0.000144	0.000773	CcSEcCtD
Halofantrine—Headache—Dexamethasone—psoriasis	0.000144	0.000773	CcSEcCtD
Halofantrine—Asthenia—Prednisone—psoriasis	0.000144	0.000771	CcSEcCtD
Halofantrine—Pruritus—Prednisone—psoriasis	0.000142	0.000761	CcSEcCtD
Halofantrine—Feeling abnormal—Methotrexate—psoriasis	0.000138	0.00074	CcSEcCtD
Halofantrine—Diarrhoea—Prednisone—psoriasis	0.000137	0.000736	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methotrexate—psoriasis	0.000137	0.000735	CcSEcCtD
Halofantrine—Nausea—Dexamethasone—psoriasis	0.000137	0.000733	CcSEcCtD
Halofantrine—Nausea—Betamethasone—psoriasis	0.000137	0.000733	CcSEcCtD
Halofantrine—Urticaria—Methotrexate—psoriasis	0.000133	0.000714	CcSEcCtD
Halofantrine—Dizziness—Prednisone—psoriasis	0.000133	0.000711	CcSEcCtD
Halofantrine—Abdominal pain—Methotrexate—psoriasis	0.000133	0.00071	CcSEcCtD
Halofantrine—Vomiting—Prednisone—psoriasis	0.000128	0.000684	CcSEcCtD
Halofantrine—Rash—Prednisone—psoriasis	0.000127	0.000678	CcSEcCtD
Halofantrine—Dermatitis—Prednisone—psoriasis	0.000126	0.000677	CcSEcCtD
Halofantrine—Headache—Prednisone—psoriasis	0.000126	0.000674	CcSEcCtD
Halofantrine—Asthenia—Methotrexate—psoriasis	0.00012	0.000645	CcSEcCtD
Halofantrine—Nausea—Prednisone—psoriasis	0.000119	0.000639	CcSEcCtD
Halofantrine—Pruritus—Methotrexate—psoriasis	0.000119	0.000636	CcSEcCtD
Halofantrine—Diarrhoea—Methotrexate—psoriasis	0.000115	0.000615	CcSEcCtD
Halofantrine—Dizziness—Methotrexate—psoriasis	0.000111	0.000594	CcSEcCtD
Halofantrine—Vomiting—Methotrexate—psoriasis	0.000107	0.000571	CcSEcCtD
Halofantrine—Rash—Methotrexate—psoriasis	0.000106	0.000567	CcSEcCtD
Halofantrine—Dermatitis—Methotrexate—psoriasis	0.000106	0.000566	CcSEcCtD
Halofantrine—Headache—Methotrexate—psoriasis	0.000105	0.000563	CcSEcCtD
Halofantrine—Nausea—Methotrexate—psoriasis	9.96e-05	0.000534	CcSEcCtD
